GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Health Guard Biotechnology Inc (BJSE:833575) » Definitions » Other Operating Expense

Beijing Health Guard Biotechnology (BJSE:833575) Other Operating Expense : ¥70.59 Mil (TTM As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Beijing Health Guard Biotechnology Other Operating Expense?

Beijing Health Guard Biotechnology's Other Operating Expense for the three months ended in Mar. 2025 was ¥0.16 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was ¥70.59 Mil.

Beijing Health Guard Biotechnology's quarterly Other Operating Expense increased from Sep. 2024 (¥-42.23 Mil) to Dec. 2024 (¥72.66 Mil) but then declined from Dec. 2024 (¥72.66 Mil) to Mar. 2025 (¥0.16 Mil).

Beijing Health Guard Biotechnology's annual Other Operating Expense declined from Dec. 2022 (¥50.51 Mil) to Dec. 2023 (¥45.53 Mil) but then increased from Dec. 2023 (¥45.53 Mil) to Dec. 2024 (¥70.58 Mil).


Beijing Health Guard Biotechnology Other Operating Expense Historical Data

The historical data trend for Beijing Health Guard Biotechnology's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Health Guard Biotechnology Other Operating Expense Chart

Beijing Health Guard Biotechnology Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.61 24.71 50.51 45.53 70.58

Beijing Health Guard Biotechnology Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 40.00 -42.23 72.66 0.16

Beijing Health Guard Biotechnology Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥70.59 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Health Guard Biotechnology Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Beijing Health Guard Biotechnology's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Health Guard Biotechnology Business Description

Traded in Other Exchanges
N/A
Address
No. 7 Rongchang East Street, Beijing Economic and Technological Development Zone, Room 201 and 202, Building A2, Beijing, CHN, 100176
Beijing Health Guard Biotechnology Inc engages in the research, development, and industrialization of recombinant protein vaccines. It mainly develops HPV vaccines in China and also advances multiple innovative candidate vaccines for other infectious diseases. Its core pipeline product includes a trivalent and a nonavalent HPV vaccine.

Beijing Health Guard Biotechnology Headlines

No Headlines